UPDATE 3-Allergan slashes full-year forecast, shares fall

Nov 2 (Reuters) - Allergan Plc reported quarterly earnings that fell far short of analysts' estimates, largely due to lower demand for its drugs, Asacol and Namenda, and the drugmaker slashed its full…
Read the full story: Reuters: Healthcare